General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 18053688)

Published in Schizophr Res on November 28, 2007

Authors

Leanne M Williams1, Thomas J Whitford, Gary Flynn, Wilson Wong, Belinda J Liddell, Steven Silverstein, Cherrie Galletly, Anthony W F Harris, Evian Gordon

Author Affiliations

1: The Brain Dynamics Centre, Westmead Millennium Institute and Western Clinical School, University of Sydney, Westmead Hospital, NSW, 2145, Australia. lea_williams@wmi.usyd.edu.au

Articles citing this

Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull (2011) 1.56

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46

Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry (2016) 1.44

Communication abnormalities predict functional outcomes in chronic schizophrenia: differential associations with social and adaptive functions. Schizophr Res (2008) 0.91

Emotion-elicited gamma synchrony in patients with first-episode schizophrenia: a neural correlate of social cognition outcomes. J Psychiatry Neurosci (2009) 0.90

Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. PLoS One (2011) 0.87

Neural synchrony in patients with a first episode of schizophrenia: tracking relations with grey matter and symptom profile. J Psychiatry Neurosci (2009) 0.86

Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients. Neuropsychobiology (2009) 0.81

A novel, online social cognitive training program for young adults with schizophrenia: A pilot study. Schizophr Res Cogn (2014) 0.81

Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls. Bipolar Disord (2013) 0.81

Effects of Δ-THC on Working Memory: Implications for Schizophrenia? Prim psychiatry (2009) 0.80

Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence. Schizophr Res Treatment (2012) 0.79

Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychol Med (2015) 0.78

The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia. Schizophr Bull (2014) 0.78

Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project. BMC Psychiatry (2016) 0.77

Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults. Psychopharmacology (Berl) (2013) 0.77

Articles by these authors

Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry (2006) 3.48

A common fold mediates vertebrate defense and bacterial attack. Science (2007) 3.43

Small-world properties of nonlinear brain activity in schizophrenia. Hum Brain Mapp (2009) 2.36

Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull (2005) 2.29

A direct brainstem-amygdala-cortical 'alarm' system for subliminal signals of fear. Neuroimage (2005) 2.17

An overview of the serpin superfamily. Genome Biol (2006) 2.14

A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol (2008) 1.98

The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity (2012) 1.89

Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int (2010) 1.83

Preservation of limbic and paralimbic structures in aging. Hum Brain Mapp (2005) 1.82

Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81

Trauma modulates amygdala and medial prefrontal responses to consciously attended fear. Neuroimage (2005) 1.77

Preliminary validity of "integneuro": a new computerized battery of neurocognitive tests. Int J Neurosci (2005) 1.76

Early life stress and morphometry of the adult anterior cingulate cortex and caudate nuclei. Biol Psychiatry (2006) 1.74

The mellow years?: neural basis of improving emotional stability over age. J Neurosci (2006) 1.74

Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry (2004) 1.70

Face to face: visual scanpath evidence for abnormal processing of facial expressions in social phobia. Psychiatry Res (2004) 1.69

Relationship between body mass index and brain volume in healthy adults. Int J Neurosci (2008) 1.69

Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res Brain Res Rev (2003) 1.69

Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Hum Brain Mapp (2007) 1.68

Using brain-based cognitive measures to support clinical decisions in ADHD. Pediatr Neurol (2010) 1.63

BDNF Val66Met polymorphism is associated with body mass index in healthy adults. Neuropsychobiology (2006) 1.56

Amygdala-prefrontal dissociation of subliminal and supraliminal fear. Hum Brain Mapp (2006) 1.55

Social phobics do not see eye to eye: a visual scanpath study of emotional expression processing. J Anxiety Disord (2003) 1.55

People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 1.53

Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull (2008) 1.52

Defining the temporal threshold for ocular fixation in free-viewing visuocognitive tasks. J Neurosci Methods (2003) 1.49

Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: an fMRI study. Hum Brain Mapp (2008) 1.47

Mode of functional connectivity in amygdala pathways dissociates level of awareness for signals of fear. J Neurosci (2006) 1.46

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46

Regional white matter and neuropsychological functioning across the adult lifespan. Biol Psychiatry (2006) 1.44

The 'when' and 'where' of perceiving signals of threat versus non-threat. Neuroimage (2006) 1.44

The effect of training on the use of tobacco-use cessation guidelines in dental settings. J Am Dent Assoc (2012) 1.41

Neural networks of information processing in posttraumatic stress disorder: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.40

The relationship between frontal gray matter volume and cognition varies across the healthy adult lifespan. Am J Geriatr Psychiatry (2006) 1.38

Mapping the time course of nonconscious and conscious perception of fear: an integration of central and peripheral measures. Hum Brain Mapp (2004) 1.37

"Gamma synchrony" in first-episode schizophrenia: a disorder of temporal connectivity? Am J Psychiatry (2005) 1.36

The neural networks of inhibitory control in posttraumatic stress disorder. J Psychiatry Neurosci (2008) 1.36

Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res (2007) 1.34

Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging. Hum Brain Mapp (2010) 1.34

Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry (2005) 1.34

Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry (2007) 1.33

Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophr Bull (2008) 1.32

A temporal dissociation of subliminal versus supraliminal fear perception: an event-related potential study. J Cogn Neurosci (2004) 1.31

Pathways for fear perception: modulation of amygdala activity by thalamo-cortical systems. Neuroimage (2005) 1.31

Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage (2006) 1.31

Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery. Arch Clin Neuropsychol (2006) 1.30

Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study. Pacing Clin Electrophysiol (2013) 1.29

The clinical translation of a measure of gain control: the contrast-contrast effect task. Schizophr Bull (2011) 1.28

Exposure to early life trauma is associated with adult obesity. Psychiatry Res (2006) 1.27

Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry (2011) 1.26

Widespread reductions in gray matter volume in depression. Neuroimage Clin (2013) 1.26

Explicit identification and implicit recognition of facial emotions: I. Age effects in males and females across 10 decades. J Clin Exp Neuropsychol (2008) 1.25

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr (2008) 1.25

The dynamics of cortico-amygdala and autonomic activity over the experimental time course of fear perception. Brain Res Cogn Brain Res (2004) 1.23

Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study. Nicotine Tob Res (2008) 1.22

Functional disconnections in the direct and indirect amygdala pathways for fear processing in schizophrenia. Schizophr Res (2007) 1.22

Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Biol Psychiatry (2008) 1.19

"Gamma (40 Hz) phase synchronicity" and symptom dimensions in schizophrenia. Cogn Neuropsychiatry (2003) 1.18

Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol (2008) 1.17

Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample. Schizophr Res (2002) 1.16

Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder. J Psychiatry Neurosci (2008) 1.15

Schizophrenia and affective disorder show different visual scanning behavior for faces: a trait versus state-based distinction? Biol Psychiatry (2002) 1.14

Category and letter verbal fluency across the adult lifespan: relationship to EEG theta power. Arch Clin Neuropsychol (2005) 1.14

Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site. Mol Pharmacol (2009) 1.13

Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11

Body mass index and neuropsychological function in healthy children and adolescents. Appetite (2007) 1.11

The subtilisin-like protease AprV2 is required for virulence and uses a novel disulphide-tethered exosite to bind substrates. PLoS Pathog (2010) 1.10

Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems. Biol Psychol (2008) 1.09

'Negativity bias' in risk for depression and anxiety: brain-body fear circuitry correlates, 5-HTT-LPR and early life stress. Neuroimage (2009) 1.08

Explicit identification and implicit recognition of facial emotions: II. Core domains and relationships with general cognition. J Clin Exp Neuropsychol (2008) 1.07

The impact of early life stress on psychophysiological, personality and behavioral measures in 740 non-clinical subjects. J Integr Neurosci (2005) 1.06

Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. Neuroimage (2011) 1.05

Posttraumatic stress disorder and prolonged grief in refugees exposed to trauma and loss. BMC Psychiatry (2014) 1.04

Early life stress and adult emotional experience: an international perspective. Int J Psychiatry Med (2006) 1.04

Patterns of cognitive performance in middle-aged and older adults: A cluster analytic examination. J Geriatr Psychiatry Neurol (2006) 1.04

Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Aust N Z J Psychiatry (2012) 1.03

Spatial localisation of actin filaments across developmental stages of the malaria parasite. PLoS One (2012) 1.03

In first presentation adolescent anorexia nervosa, do cognitive markers of underweight status change with weight gain following a refeeding intervention? Int J Eat Disord (2010) 1.02

Duration of posttraumatic stress disorder predicts hippocampal grey matter loss. Neuroreport (2009) 1.02

Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro. Behav Res Methods (2007) 1.02

Distinct amygdala-autonomic arousal profiles in response to fear signals in healthy males and females. Neuroimage (2005) 1.01